There continues to be a high unmet medical need in patients with - TopicsExpress



          

There continues to be a high unmet medical need in patients with lung cancer. To address this need, ACS and ACS-CAN are working to invest in opportunities to expand our advocacy and research efforts to support the Enterprise Program of Work. Building on this body of work, the Society is joining forces with other leaders to support the development of a first of its kind, clinical trial collaborative. Lung-MAP is a multi-drug, multi-arm, biomarker-driven clinical trial for patients with squamous cell lung cancer that will make it easier for patients and researchers to find one another. This bold initiative to find new treatments launches today: bit.ly/1n4ce2V
Posted on: Mon, 16 Jun 2014 16:00:32 +0000

Trending Topics



Recently Viewed Topics




© 2015